Xiidra

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0078-0911
  • Package NDC 0078-0911-12
  • Package NDC 0078-0911-94
  • Application number NDA208073
  • SPL ID 3cabbaea-c2bf-971c-e063-6394a90a4931
  • SPL set ID 8589d376-ac10-4ddb-9c53-2e0c8d5675c4
  • UNII 038E5L962W
  • RxCUI 1801835
  • RxCUI 1801840

What the source publishes

Labeler
Novartis Pharmaceuticals Corporation
Active ingredients
Lifitegrast
Form
SOLUTION/ DROPS
Routes
OPHTHALMIC
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0078-0911_3cabbaea-c2bf-971c-e063-6394a90a4931
{
  "name": "Xiidra",
  "splId": "3cabbaea-c2bf-971c-e063-6394a90a4931",
  "labels": [
    {
      "setId": "8589d376-ac10-4ddb-9c53-2e0c8d5675c4",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8589d376-ac10-4ddb-9c53-2e0c8d5675c4",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8589d376-ac10-4ddb-9c53-2e0c8d5675c4"
    }
  ],
  "routes": [
    "OPHTHALMIC"
  ],
  "labeler": "Novartis Pharmaceuticals Corporation",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "12 POUCH in 1 CARTON (0078-0911-12)  / 5 AMPULE in 1 POUCH (0078-0911-05)  / .2 mL in 1 AMPULE",
      "package_ndc": "0078-0911-12",
      "identifierStatus": "well-formed",
      "marketing_end_date": "20270601",
      "marketing_start_date": "20200604"
    },
    {
      "sample": true,
      "description": "4 POUCH in 1 CARTON (0078-0911-94)  / 5 AMPULE in 1 POUCH (0078-0911-95)  / .2 mL in 1 AMPULE",
      "package_ndc": "0078-0911-94",
      "identifierStatus": "well-formed",
      "marketing_end_date": "20270201",
      "marketing_start_date": "20200604"
    }
  ],
  "productId": "0078-0911_3cabbaea-c2bf-971c-e063-6394a90a4931",
  "useDomain": "unknown",
  "dosageForm": "SOLUTION/ DROPS",
  "productNdc": "0078-0911",
  "deaSchedule": null,
  "genericName": "Lifitegrast",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LIFITEGRAST",
      "strength": "50 mg/mL"
    }
  ],
  "applicationNumber": "NDA208073",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20160711",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000192701",
      "N0000192700"
    ],
    "unii": [
      "038E5L962W"
    ],
    "rxcui": [
      "1801835",
      "1801840"
    ],
    "spl_set_id": [
      "8589d376-ac10-4ddb-9c53-2e0c8d5675c4"
    ],
    "pharm_class_epc": [
      "Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]"
    ],
    "pharm_class_moa": [
      "Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]"
    ],
    "manufacturer_name": [
      "Novartis Pharmaceuticals Corporation"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0078-0911_3cabbaea-c2bf-971c-e063-6394a90a4931"